6533b871fe1ef96bd12d24c8
RESEARCH PRODUCT
Immunosuppressive treatment for systemic sclerosis—Therapeutic challenges during the COVID ‐19 pandemic
Lidia RudnickaLeszek BlicharzZbigniew SamochockiMohamad GoldustMohamad GoldustMohamad GoldustMalgorzata OlszewskaJoanna Czuwarasubject
2019-20 coronavirus outbreakmedicine.medical_specialtyLetterCoronavirus disease 2019 (COVID-19)systemic sclerosisPneumonia ViralDermatologySclerodermaCOVID‐19Risk FactorsPsoriasisPandemicmedicineHumansPsoriasisLettersIntensive care medicinePandemicsImmunosuppressive treatmentbusiness.industryCOVID-19immunosuppressive treatmentGeneral Medicinemedicine.diseasePneumoniaCoronavirus InfectionsbusinessImmunosuppressive AgentsCoronavirus Infectionsyear | journal | country | edition | language |
---|---|---|---|---|
2020-06-30 | Dermatologic Therapy |